These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 10448130)

  • 21. [Identification of cancer antigens of relevance for specific cancer immunotherapy].
    van den Eynde B
    Bull Mem Acad R Med Belg; 2001; 156(10-12):548-55. PubMed ID: 12371273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo anti-melanoma activities of the Melan-A/MART-1(101-115) T CD4+ cell peptide.
    Balasse E; Gatouillat G; Patigny D; Andry MC; Madoulet C
    Vaccine; 2009 Oct; 27(44):6107-9. PubMed ID: 19686694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer-germline antigen vaccines and epigenetic enhancers: future strategies for cancer treatment.
    Gjerstorff MF; Burns J; Ditzel HJ
    Expert Opin Biol Ther; 2010 Jul; 10(7):1061-75. PubMed ID: 20420535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer. Cancer immunotherapy is more than a numbers game.
    Offringa R
    Science; 2006 Oct; 314(5796):68-9. PubMed ID: 17023641
    [No Abstract]   [Full Text] [Related]  

  • 25. An overview of the GAGE cancer/testis antigen family with the inclusion of newly identified members.
    Gjerstorff MF; Ditzel HJ
    Tissue Antigens; 2008 Mar; 71(3):187-92. PubMed ID: 18179644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictive gene signature in MAGE-A3 antigen-specific cancer immunotherapy.
    Ulloa-Montoya F; Louahed J; Dizier B; Gruselle O; Spiessens B; Lehmann FF; Suciu S; Kruit WH; Eggermont AM; Vansteenkiste J; Brichard VG
    J Clin Oncol; 2013 Jul; 31(19):2388-95. PubMed ID: 23715562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression, purification and characterization of the cancer-germline antigen GAGE12I: a candidate for cancer immunotherapy.
    Gjerstorff MF; Besir H; Larsen MR; Ditzel HJ
    Protein Expr Purif; 2010 Oct; 73(2):217-22. PubMed ID: 20546897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential role of dendritic cell vaccination with MAGE peptides in gastrointestinal carcinomas.
    Tanaka F; Haraguchi N; Isikawa K; Inoue H; Mori M
    Oncol Rep; 2008 Nov; 20(5):1111-6. PubMed ID: 18949409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The expression of MAGE and GAGE genes in uterine cervical carcinoma of Korea by RT-PCR with common primers.
    Chang HK; Park J; Kim W; Kim K; Lee M; Park U; Choi B
    Gynecol Oncol; 2005 May; 97(2):342-7. PubMed ID: 15863128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new MAGE gene with ubiquitous expression does not code for known MAGE antigens recognized by T cells.
    Lucas S; Brasseur F; Boon T
    Cancer Res; 1999 Aug; 59(16):4100-3. PubMed ID: 10463614
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rhabdomyosarcomas are potential target of MAGE-specific immunotherapies.
    Tanzarella S; Lionello I; Valentinis B; Russo V; Lollini PL; Traversari C
    Cancer Immunol Immunother; 2004 Jun; 53(6):519-24. PubMed ID: 14727086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential expression profile of MAGE family in non-small-cell lung cancer.
    Tsai JR; Chong IW; Chen YH; Yang MJ; Sheu CC; Chang HC; Hwang JJ; Hung JY; Lin SR
    Lung Cancer; 2007 May; 56(2):185-92. PubMed ID: 17208331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer immunotherapy with MAGE antigens.
    Coulie PG
    Suppl Tumori; 2002; 1(4):S63-5. PubMed ID: 12415826
    [No Abstract]   [Full Text] [Related]  

  • 34. [The function of tumor specific antigen (MAGE) in tumor immunotherapy].
    Fang JB; Wang L
    Sheng Li Ke Xue Jin Zhan; 2005 Jul; 36(3):273-5. PubMed ID: 16270835
    [No Abstract]   [Full Text] [Related]  

  • 35. Tumor antigen expression in melanoma varies according to antigen and stage.
    Barrow C; Browning J; MacGregor D; Davis ID; Sturrock S; Jungbluth AA; Cebon J
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):764-71. PubMed ID: 16467087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Molecular biology of lung cancer series].
    Hiret S; Senellart H; Bennouna J
    Rev Mal Respir; 2010 Oct; 27(8):954-8. PubMed ID: 20965409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of melanoma-associated antigens in oral squamous cell carcinoma.
    Ries J; Vairaktaris E; Mollaoglu N; Wiltfang J; Neukam FW; Nkenke E
    J Oral Pathol Med; 2008 Feb; 37(2):88-93. PubMed ID: 18197853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of peptide-specific immune response in patients with primary malignant melanoma of the esophagus after immunotherapy using dendritic cells pulsed with MAGE peptides.
    Ueda Y; Shimizu K; Itoh T; Fuji N; Naito K; Shiozaki A; Yamamoto Y; Shimizu T; Iwamoto A; Tamai H; Yamagishi H
    Jpn J Clin Oncol; 2007 Feb; 37(2):140-5. PubMed ID: 17255158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccine-induced CD8+ T-cell responses to MAGE-3 correlate with clinical outcome in patients with melanoma.
    Reynolds SR; Zeleniuch-Jacquotte A; Shapiro RL; Roses DF; Harris MN; Johnston D; Bystryn JC
    Clin Cancer Res; 2003 Feb; 9(2):657-62. PubMed ID: 12576432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Melanoma vaccines: achievements and perspectives.
    Brichard VG; Gérard C
    Forum (Genova); 2003; 13(2):144-54; quiz 189. PubMed ID: 14732881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.